ArticleLife (Basel, Switzerland)2021
Predicting Three-Dimensional Dose Distribution of Prostate Volumetric Modulated Arc Therapy Using Deep Learning.
Article in Life (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Deep learning-based dose prediction for stereotactic prostate cancer radiotherapy with CyberKnife.Journal of applied clinical medical physics · 2026Article
- End-to-end deep learning pipeline for automated IMRT planning in lymphoma: Feasibility and limitations.Journal of applied clinical medical physics · 2026Article
- Transformer-Integrated Hybrid Convolutional Neural Network for Dose Prediction in Nasopharyngeal Carcinoma Radiotherapy.Journal of imaging informatics in medicine · 2025Article
- Nested CNN architecture for three-dimensional dose distribution prediction in tomotherapy for prostate cancer.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundVolumetric modulated arc therapy (VMAT) planning is a time-consuming process of radiation therapy. With a deep learning approach, 3D dose distribution can be predicted without the need for an actual dose calculation. This approach can accelerate the process by guiding and confirming the achievable dose distribution in order to reduce the replanning iterations while maintaining the plan quality.
methodsIn this study, three dose distribution predictive models of VMAT for prostate cancer were developed, evaluated, and compared. Each model was designed with a different input data structure to train and test the model: (1) patient CT alone (PCT alone), (2) patient CT and generalized organ structure (PCTGOS), and (3) patient CT and specific organ structure (PCTSOS). The generative adversarial network (GAN) model was used as a core learning algorithm. The models were trained slice-by-slice using 46 VMAT plans for prostate cancer, and then used to predict and evaluate the dose distribution from 8 independent plans.
resultsVMAT dose distribution was generated with a mean prediction time of approximately 3.5 s per patient, whereas the PCTSOS model was excluded due to a mean prediction time of approximately 17.5 s per patient. The highest average 3D gamma passing rate was 80.51 ± 5.94, while the lowest overall percentage difference of dose-volume histogram (DVH) parameters was 6.01 ± 5.44% for the prescription dose from the PCTGOS model. However, the PCTSOS model was the most reliable for the evaluation of multiple parameters.
conclusionsThis dose prediction model could accelerate the iterative optimization process for the planning of VMAT treatment by guiding the planner with the desired dose distribution.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.